Titan Biotech Hits New 52-Week High of Rs. 1185, Showcases Strong Momentum

Titan Biotech has reached a significant milestone by hitting a new 52-week high of Rs. 1185 on October 10, 2025. This achievement marks a notable performance for the microcap company in the specialty chemicals industry, as it has outperformed its sector by 4.69% today. The stock has shown impressive momentum, gaining consecutively for the last nine days and delivering a remarkable 31.31% return during this period.
In today's trading session, Titan Biotech recorded an intraday high of Rs. 1185, reflecting a 4.78% increase, while the day's low was Rs. 1090, down by 3.62%. The stock is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong upward trend.

In the broader market context, the Sensex has shown resilience, recovering from an initial dip and trading at 82,451.50, just 2% shy of its own 52-week high. The small-cap sector is leading the market, with the BSE Small Cap index gaining 0.64%. Titan Biotech's performance over the past year stands at an impressive 58.22%, significantly outpacing the Sensex's 1.03% return.